Serum metabolomics identifies GPC depletion in hepatic encephalopathy and its therapeutic potential for cognitive impairment.

Chen H, Xing X, Ding X, Xiang G, Li J, Yang Y, Liu Q, Xu K, Lei Q, Li P.

Open source

DOI
10.3389/fphar.2026.1807444
Published
2026-04-29
Container
Front Pharmacol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1807444,
  title = {Serum metabolomics identifies GPC depletion in hepatic encephalopathy and its therapeutic potential for cognitive impairment.},
  author = {Chen H and  Xing X and  Ding X and  Xiang G and  Li J and  Yang Y and  Liu Q and  Xu K and  Lei Q and  Li P.},
  year = {2026},
  journal = {Front Pharmacol},
  doi = {10.3389/fphar.2026.1807444},
  url = {https://doi.org/10.3389/fphar.2026.1807444}
}

RIS

TY  - JOUR
TI  - Serum metabolomics identifies GPC depletion in hepatic encephalopathy and its therapeutic potential for cognitive impairment.
AU  - Chen H
AU  -  Xing X
AU  -  Ding X
AU  -  Xiang G
AU  -  Li J
AU  -  Yang Y
AU  -  Liu Q
AU  -  Xu K
AU  -  Lei Q
AU  -  Li P.
PY  - 2026
JO  - Front Pharmacol
DO  - 10.3389/fphar.2026.1807444
UR  - https://doi.org/10.3389/fphar.2026.1807444
ER  - 

APA

H, C., X, X., X, D., G, X., J, L., Y, Y., Q, L., K, X., Q, L., & P., L. (2026). Serum metabolomics identifies GPC depletion in hepatic encephalopathy and its therapeutic potential for cognitive impairment.. Front Pharmacol. https://doi.org/10.3389/fphar.2026.1807444

Source records